Ocumetics Eyes First In-human Trials of Accommodating Lens Technology in Early 2024
Ocumetics Technology (TSXV:OTC,OTCQB:OTCFF,FWB:2QBO) has successfully completed a biocompatibility animal study for its proprietary Ocumetics Accommodating Lens, and according to President and CEO Dean Burns, the company is gearing up to…